Paid Psoriasis Clinical Trials

Candace Kastanis

Written by Candace Kastanis

Chemistry B.S. | UC Davis | Clinical Lab Technician

Updated & Fact Checked 3/07/23

What are paid psoriasis clinical trials?

how to find clinical trials

Psoriasis is a skin condition characterized by red, unsightly patches thought to be an immune system problem. Paid psoriasis clinical trials allow researchers to study potential causes and treatments. Volunteers with psoriasis symptoms can receive payment for their participation and get treated with a pre-market, no-cost treatment option that may provide relief.

How do I find paid psoriasis clinical trials for healthy volunteers near me?

Your dermatologist or primary physician may recommend you for a particular paid psoriasis clinical study if your current treatment is not offering measurable relief. Other paid clinical trial opportunities are easily accessible on government-based public health websites. In some cases, clinical trial sponsors may host informational seminars regarding any approaching clinical trials at your local clinic or hospital.

Swiss Dermatology Network of Targeted Therapies (SDNTT)
Recruiting
The purpose of this study is to evaluate the long-term course of patients with psoriasis and psoriatic-arthritis in systemic treatments such as, methotrexate, cyclosporin A, fumaric acids, acitretin, systemic PUVA, etanercept, infliximab, adalimumab and ustekinumab. A patient will be included at first initiation of the treatment and will remain in the registry for 10 years, regardless of subsequent therapy. The registry will also evaluate safety clinical outcomes and health related quality of l... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/27/2024
Locations: Aarau Cantonal Hospital, Aarau, Not set +5 locations
Conditions: Psoriasis
PsoBest - the German Psoriasis Registry
Recruiting
Treatment of moderate to severe Psoriasis (Pso) and Psoriasis-Arthritis (PsA) is largely confined to systemic therapy in Germany. Systemic therapy includes conventional systemic therapy (e.g. fumaric acids, methotrexate, ciclosporin A) and biological treatment (e.g. adalimumab, etanercept). While short- and middle-term efficacy of most systemic treatments has been shown in clinical studies (and is incorporated in international guidelines), knowledge about long-term outcomes, optimal treatment an... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/23/2025
Locations: Nationwide group of dermatological centers, hospitals and medical offices, Hamburg, Not set
Conditions: Psoriasis, Psoriatic-arthritis
Spanish Registry of Systemic Treatments in Psoriasis
Recruiting
The purpose of Biobadaderm is a to study the safety of systemic therapy in psoriasis.
Gender:
ALL
Ages:
All
Trial Updated:
03/15/2022
Locations: Hospital Universitari German Trias y Pujol., Badalona, Barcelona +12 locations
Conditions: Psoriasis
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
Recruiting
The purpose of the OTIS Autoimmune Diseases in Pregnancy Study is to monitor planned and unplanned pregnancies exposed to certain medications, to evaluate the possible teratogenic effect of these medications and to follow live born infants for one year after birth. With respect to fetal outcome, it is important to evaluate the spectrum of outcomes that may be relevant to a medication exposure during pregnancy, and these include both easily recognizable defects which are visible at birth, as well... Read More
Gender:
FEMALE
Ages:
All
Trial Updated:
01/26/2025
Locations: University of California, San Diego, La Jolla, California
Conditions: Psoriasis, Pregnancy, Psoriatic Arthritis, Crohn Disease
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Recruiting
Psoriasis has been associated with an increasing risk for atherosclerosis. The investigators investigated whether surrogate markers of subclinical atherosclerosis, vascular dysfunction and myocardial dysfunction are impaired in patients with psoriasis compared to normal controls ,coronary artery disease patients and untreated hypertension subjects. The investigators also examined the effect of treatment with biological vs no biological agents on vascular and LV function in psoriasis.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
05/14/2023
Locations: Attikon Hospital, Athens, Not set
Conditions: Psoriasis
Regulation of Inflammatory Genes in Psoriasis
Recruiting
Psoriasis is a chronic and recurrent skin disorder characterized by marked inflammatory changes in the skin. An extensive cytokine network including generated by activated dendritic cells and T cells mediates the formation of psoriatic lesions. These immune-response parameters can be used as markers in the severity and management of the disease after further in-depth studies.
Gender:
ALL
Ages:
Between 19 years and 99 years
Trial Updated:
03/24/2025
Locations: The Kirklin Clinic, Birmingham, Alabama
Conditions: Psoriasis, Inflammation
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
Recruiting
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Brodalumab in Pediatric Subjects
Gender:
ALL
Ages:
Between 6 years and 18 years
Trial Updated:
08/09/2023
Locations: Bausch Site 003, San Diego, California +4 locations
Conditions: Psoriasis
Molecular Signatures in Inflammatory Skin Disease
Recruiting
This pilot project intends to examine the utility of a systems medicine approach to identify regulatory networks and their perturbation in psoriasis and atopic dermatitis, and to obtain a comprehensive perspective on disease and disease control by integrating and modelling data across multiple cellular levels and time following specific blockade of single pathophysiological factors through use of licensed biologics during routine care as systems biology challenge. To this end, ultra-deep phenoty... Read More
Gender:
ALL
Ages:
All
Trial Updated:
07/17/2025
Locations: Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Not set
Conditions: Atopic Dermatitis, Psoriasis
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Recruiting
The clinical study investigates the long-term course of disease in patients with chronic inflammatory skin diseases (atopic eczema and psoriasis) and the impact of tarheted therapies on the clinical and molecular level. For this purpose, patients are asked to take part in regular examinations and data collections, and to donate biomaterials (blood, skin biopsies, skin swabs, tape strips, stool samples). Blood samples are used to analyze inflammation messengers. Punch biopsies from lesional and n... Read More
Gender:
ALL
Ages:
Between 0 years and 100 years
Trial Updated:
07/17/2025
Locations: Department of Dermatology, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Not set
Conditions: Atopic Dermatitis, Psoriasis, Healthy
An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for Twelve Weeks in Moderate-to-Severe Psoriasis Patients
Recruiting
A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of response.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/29/2019
Locations: Elise Nelson, East Windsor, New Jersey
Conditions: Psoriasis

Who conducts paid psoriasis clinical trials for healthy volunteers?

Paid psoriasis clinical studies can be hosted by research firms, public health agencies, educational institutions, or pharmaceutical companies. Psoriasis is a complex condition without a known cure; consequently, the scientific community is committed to developing more effective treatment options.


What are the advantages of participating in a paid psoriasis clinical trial?

The primary advantage of participating in a paid psoriasis clinical trial is an opportunity to try a new treatment without any out-of-pocket costs. Psoriasis is a chronic condition and remains hard to treat. Previous treatments consisted of mainly steroidal-based topical soaps and creams that typically lose effectiveness after a few applications. Due to advances in mRNA-based therapeutics, we have newer, more effective treatments. With the help of your participation in paid clinical trials, researchers can explore methods to expand on that success.


What are the disadvantages of participating in a paid psoriasis clinical trial?

Understandably, not all treatments will yield success in all individuals. Dealing with a stigmatizing skin condition is difficult. The letdown can be tremendous should the therapeutic study product fails toprovidesatisfactory results. Additionally, there is the possibility of measurable discomfort associated with any testing procedures, drug administration, and the potential for side effects.


How does a paid psoriasis clinical trial work?

The clinical pathway towards gaining FDA approval is a four-stage process. Within that process, is an opportunity to demonstrate the drug’s effectiveness towards the intended treatment. The only way to achieve this is to test the product on individual patients who already suffer from psoriasis. Therefore, they begin to reach out to local hospitals and doctors to help recruit qualified patients.

The recruitment profile may include a diagnosis of psoriasis of any kind despite any length of time, a specific age group or geographical location. The eligibility criteria could differ quite a bit depending on the clinical sponsor and the type of therapeutic.

To attract the number of patients they need, clinical sponsors offer payment and/or a stipend to those chosen to participate. The requirements could be as simple as maintaining a video diary or as complex as weekly visits. However, to receive full payment you will need to complete all necessary appointments, undergoing various tests, and procedures as required by the investigator team.

Depending on the study phase you are participating in, it is possible you may be given a placebo. Cure, or optimal treatment outcomes are not always the case when participating in a paid psoriasis clinical study. The FDA does however require strict adherence to the informed consent criteria necessary to ensure patient safety.

Consequently, the clinical investigator would have to disclose if there was a chance you may be getting a placebo vs. The treatment medication allowing you to make an informed decision to participate in a paid psoriasisclinical trial.


What do researchers learn from conducting paid psoriasis clinical trials?

Previous psoriasis-specific clinical trials indicate the causes are more complex than previously thought. Recent clinical evidence suggests psoriasis is a result of a challenged immune system. Though a cure is not yet in development, the treatment options available offer dramatically improved results from prior generations of therapeutic choices. As such, the potential in this space holds tremendous promise for patients struggling with painful skin patches.

Further studies may offer insight regarding:

  • What mRNA therapeutics may work best in specific patient populations i.e., women who are pregnant, children, seniors, etc.
  • Which drug interactions may pose a threat.
  • How a patient may respond in general (is the drug therapeutic as effective as those previously used).
  • How stress, diet, or biological changes may contribute to the skin condition.
  • Which genetic biomarkers play a role.

Commonly Asked Questions (FAQs)

  • How much are paid psoriasis clinical trial participants paid on average?

    The payment amounts for paid volunteers vary depending on the type of trial and sponsor, the risk involved, and the anticipated length of the study. Traditionally, the paid volunteer receives a stipend for travel, out-of-pocket expenses, over-the-counter medications, home care, and meals.

  • How do I find out if I am eligible to participate in a paid psoriasis clinical trial?

    Clinical trial and eligibility information relating to paid psoriasis clinical trials require a documented medical history of problems associated with psoriasis. The clinical study coordinator or team lead may determine eligibility based on failed previous drug interventions, the current impact on your current health, and any risk factors that make participation a good option.

    Study coordinators may also take an in-depth look at your behavioral health and lifestyle choices to determine if you are an ideal fit for the therapeutic intervention. More information is usually available on the clinical sponsor’s website.

  • Will participation in a paid psoriasis clinical trial prevent me from leaving prior to completion?

    Withdrawing from a paid psoriasis clinical trial is permitted for any reason. Most clinical care coordinators provide patients with in-depth information at the beginning of the clinical trial so they can decide based on personal readiness, and aptitude for completion.

    Common Reasons Cited by Participants for Discontinuing a Paid Psoriasis Clinical Trial

    • Adverse reactions from the study therapeutic type
    • Financial hardship or job conflict
    • Unplanned family circumstances such as trouble finding childcare, a move etc.
    • Discouragement
    • Adverse health situation
    • Transportation

  • What type of information is normally collected in paid psoriasis clinical trials?

    Psoriasis features red, scaly skin patches that may require a video and pictures to determine severity, progress, and regression at various points during the trial. Doctors may also take skin samples or a biopsy. Researchers will collect a full scope of pre- and post-clinical study patient health values typically attained by routine blood testing.

    Those values may be related to genomic information such as family health or known precursors relative to your condition. Data points such as age, weight, ethnic background, gender, lifestyle, medications, and drug use will help formulate a comprehensive picture of the clinical study findings revealed at the study’s conclusion.

    The final report may include:

    • Any adverse effects.
    • Changes to new or existing areas of the skin.
    • Personal experience.
    • Enhanced risk factors
    • Health complications

  • How long do paid psoriasis clinical trials last?

    Paid psoriasis clinical trials do not have a set timeline with them and vary in length based on a myriad of factors such as:

    • Clinical trial design and type
    • Clinical sponsor
    • Type of drug intervention
    • Behavioral and lifestyle considerations

  • If I am interested in participating in a paid psoriasis clinical trial, what questions should I ask?

    The clinical trial coordinator is responsible for addressing any concerns at any point during your clinical trial experience. The NIH maintains clear guidance for orchestrating a transparent clinical trial experience with a strong emphasis on patient safety.

    Termed as informed consent, the clinical trial sponsors must disclose must the following information:

    1. The comprehensive nature of the treatment, procedure, or drug.
    2. Any inherent risks associated with the intended treatment methods.
    3. Reasonable alternatives to the procedure or treatment intervention.
    4. Assessment and acknowledgment that you, the patient, are in complete understanding of items 1-3.

    Informed consent is required and articulates the agreement between you, your healthcare physician, and clinical trial sponsors. The purpose of informed consent is to provide the patient with the details of every facet of the intended clinical trial study plan. This goal of informed consent is to establish trust and confidence between the eligible participant and the clinical trial sponsor team leads.

  • What to ask:

    – Inquire as to the goals or aim of the paid clinical trial.
    – Ask about the potential for long-term complications.
    – Clarify the stipend amounts for any paid compensation and travel expenses.
    – You may ask if family members may accompany you during hospital stays or doctor visits.
    – It would be appropriate to ask questions related to likelihood of discomfort, pain, or side effects that may be experienced.
    – Inquire about the number of clinical visits may be expected.
    – Ask what home-care services and strategies are available during the paid clinical trial.
    – Ask about any emergency protocols and procedures.
    – Inquire about a need to be hospitalized and any associated costs.
    – Some clinical studies are randomized trial designs where they include the use of a placebo. Therefore, asking what type of trial design and what is involved with the paid clinical study you are interested in.
    – Inquire about the endpoint findings and any access to results.
    – Inquire as to the number of patients will be recruited.